A Randomized, Phase 3, Double-Blind, Crossover Comparison of Multilayer, Extended-Release Methylphenidate (PRC-063), and Lisdexamfetamine in the Driving Performance of Young Adults With ADHD.
Vishal MadaanSailaja BhaskarGraeme A E DonnellyDaniel J CoxPublished in: Journal of attention disorders (2024)
PRC-063 and LDX had comparable effects on driving performance, from 1 through 15 hours, the last time point measured.